Amgen, GSK End Marketing Partnership for Osteoporosis Drug

by Fox Business, Benzinga Contributor
April 3, 2014 4:02 PM | 5 seconds read |

Amgen and GlaxoSmithKline terminated their five-year old collaborative marketing agreement this week ahead of schedule. 

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!